Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hemostatic Drugs in Endoscopic Lumbar Fusion
NCT06255366Phase 4Not yet recruiting
- Sponsor
- Chengdu University of Traditional Chinese Medicine
- Start
- Mar 2024
- Primary completion
- Dec 2024
- Modality
- Peptides, Small Molecules
01
Overview
A Phase 4 trial of carbazochrome sodium sulfonate, desmopressin in lumbar spondylolisthesis, sponsored by Chengdu University of Traditional Chinese Medicine. Planned start Mar 2024; status: not yet recruiting.
02
Drugs
carbazochrome sodium sulfonatedesmopressin
03
Conditions
lumbar spondylolisthesis
Beyond the preview
Go deeper on NCT06255366.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06255366.